Assembly Biosciences Inc reports results for the quarter ended in September 30 - Earnings Summary
08/11/2024 04:50
* Assembly Biosciences Inc ASMB.OQ reported a quarterly
adjusted
loss of $1.51 per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-3.24. The mean expectation of three analysts
for the quarter was for a loss of $2.02 per share. Wall Street
expected results to range from $-2.19 to $-1.85 per share.
* Revenue was $6.85 million; analysts expected $8.64
million.
* Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of $1.51.
* The company reported a quarterly loss of $9.61 million.
* Assembly Biosciences Inc shares had risen by 10.0% this
quarter and gained 69.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 9.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Assembly
Biosciences Inc is 35.50
This summary was machine generated from LSEG data November 8 at
04:50 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -2.02 -1.51 Beat
Jun. 30 2024 -2.23 -1.98 Beat
Mar. 31 2024 -3.23 -1.66 Beat
Dec. 31 2023 -2.88 -2.15 Beat